Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer
Maurizio Chiriva‐Internati(Texas Tech University), W. Martin Kast(University of Southern California), Leonardo Mirandola, Martin J. Cannon(University of Arkansas for Medical Sciences), Fred Hardwicke(Texas Tech University), Everardo Cobos(Texas Tech University), Yuefei Yu(Texas Tech University), Nicholas D’Cunha(Texas Tech University)
Cited by 53
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
|The Journal of Immunology|2001|533